Skip to Content
Find More Like This
Return to Search

Potential Prognostic Markers and Therapeutic Targets for Neurological Disorders

United States Patent Application

View the Complete Application at the US Patent & Trademark Office
Lawrence Berkeley National Laboratory - Visit the Technology Transfer and Intellectual Property Management Department Website
We recently found that Satb1 is expressed highly by mature neurons in specific regions of the postnatal brain. Satb2, a homolog of Satb1, is expressed at low levels in the postnatal brain. Neurons respond to external stimuli and rapidly and dynamically change their expression. Satb1 has been found to directly regulate a set of genes in the postnatal brain, presumably playing a crucial role as a `genome organizer` for brain function and behaviors. Satb2 may also have a similar function, even though it is expressed at low levels in the postnatal brain. The present invention describes compositions, reagents and tools using wild type and variant SATB1 and SATB2 genes and proteins for use in diagnosis, prognosis and therapeutics in neurological dysfunction and psychiatric disorders.
Kohwi-Shigematsu, Terumi (El Cerrito, CA), Kohwi, Yoshinori (El Cerrito, CA)
The Regents of the University of California (Oakland CA)
12/ 970,878
December 16, 2010
STATEMENT OF GOVERNMENTAL SUPPORT [0003] This invention was made during work supported under Grant No. R37CA039681-24 awarded by the National Cancer Institute of the National Institutes of Health, and under Contract No. DE-AC02-05CH11231 awarded by the U.S. Department of Energy. The government has certain rights in this invention.